In recent years, there is growing interest in alternative treatments for both inflammatory bowel disease and irritable bowel syndrome.
Digestive Disease Week AGA Symposium: Celiac Disease and Gut Microbiota
20 Jul 2015by Stefan Jellbauer
Quality and quantity of gluten, maturity of gut functions influencing antigen trafficking and handling (e.g. pattern recognition receptors and barrier function) and changes in microbiome composition are factors that contribute to the pathogenesis of the disease.
Digestive Disease Week AGA Symposium: Microbiome, Metabolites and Cancer
2 Jul 2015by Stefan Jellbauer
Do specific microbiota determine levels of specific metabolites? How does the metabolite profile develop during establishment of the microbiome in infants? Can we assess an individual’s physiological state based on gut flora and metabolites?
Digestive Disease Week Symposium: Gut Microbiome and Clinical Outcomes in Pediatrics
11 Jun 2015by Stefan Jellbauer
An interesting translational symposium of the American Association of Gastroenterology (AGA) at this year’s Digestive Disease Week (DDW) in Washington, D.C., was entitled, “Gut Microbiome and Clinical Outcomes in Pediatrics”.